Faster than the virus

By Anton Paar

In the past, due to cost, the polio vaccine in India was only ever administered as an oral vaccination. Indian businessman Cyrus S Poonawalla’s proposal was to produce a low-cost injectable polio vaccine (IPV) as part of his long-term vision to protect every single child in India and eventually worldwide from the worst childhood diseases. In his quest to create the affordable IPV, he turned to the expertise and technology of Bilthoven Biologicals, a Dutch vaccine manufacturer and research institute located near Ultrecht, as Maurice Mooijman and Christine Maitz of Anton Paar explain.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.